1. Jump to content.

Betaseron.com

Healthcare Professionals

Introducing the Thinnest Needle in MS Therapy

Now BETASERON may help make starting and staying on an effective MS treatment easier to achieve.

Learn More About the Thinnest Needle in MS

Multiple Sclerosis (MS) doesn't wait...
...neither should you when it comes to treating your MS.

Starting BETASERON early may help you maximize your treatment benefits because only BETASERON offers:

Hear about the new Thinnest Needle in MS

Real People, Real Stories

Hear from Brett
Individual results may vary.

Hear firsthand from Brett, who is living with MS and has used the new thinnest needle in multiple sclerosis.

If you have any questions, please call: 1-800-788-1467

View Video

* Some restrictions apply. Patients enrolled in any type of government insurance are not eligible. Void where prohibited by law, taxed, or restricted.

** In an independent study, BETAPLUS (formerly MS Pathways) was rated significantly higher on how valuable it is to people living with MS compared with other MS support programs.

INDICATIONS AND USAGE

BETASERON® (interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

IMPORTANT SAFETY INFORMATION

The most commonly reported adverse reactions are lymphopenia, injection-site reaction, asthenia, flu-like symptom complex, headache, and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms. BETASERON should be used with caution in patients with depression. Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

For important risk and use information, please see the full prescribing information.

Bayer Pharmaceuticals


This site makes use of the latest version of the Macromedia Flash Player. Download the player now!

You are now leaving www.betaseron.com website.

Bayer HealthCare Pharmaceuticals Inc. is not responsible for the content presented by any independent website, including any advertising claims, special offers, illustrations, names or endorsements.

Thank you for visiting www.betaseron.com.

OK Cancel
The information requested is intended for US healthcare professionals only.

OK Cancel
Get Adobe ReaderThe requested information is provided in Portable Document Format (PDF). To view and print this document you'll need to install a copy of the free Adobe® Acrobat® Reader®. If you already have Adobe Acrobat Reader installed click "VIEW PDF" below. If you need the Acrobat Reader you can download it from the Adobe Acrobat Reader Download page.
View PDF Cancel
Don't show me this message again.